NEWS ROOM
- 2024.10.02Meiji Seika Pharma Submits Application to Amend Approval for KOSTAIVE®, a Self-Amplifying mRNA Vaccine against COVID-19, to Include Domestic Manufacturing Site in Japan Topics
- 2024.09.10Axcelead DDP Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals Press Release
- 2024.09.05Axcelead DDP and Lilly Enter into Research and Collaboration Agreement Press Release
- 2024.07.30ARCALIS Signs Collaboration Agreement with the National Cancer Center Japan for Research, Development and Manufacturing of mRNA Pharmaceuticals Press Release
- 2024.07.26Axcelead Establishes ‘Impact’ Category on Company Website to Showcase Efforts in Impact Management Press Release